Bristol Capital Stock from 2010 to 2025

BMY Stock  USD 59.14  0.38  0.65%   
Bristol Myers Capital Stock yearly trend continues to be fairly stable with very little volatility. Capital Stock will likely drop to about 258.1 M in 2025. Capital Stock is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. View All Fundamentals
 
Capital Stock  
First Reported
1999-09-30
Previous Quarter
292 M
Current Value
292 M
Quarterly Volatility
28.7 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bristol Myers financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bristol Myers' main balance sheet or income statement drivers, such as Depreciation And Amortization of 11.8 B, Interest Expense of 1.4 B or Selling General Administrative of 3.6 B, as well as many indicators such as Price To Sales Ratio of 2.98, Dividend Yield of 0.0374 or PTB Ratio of 6.92. Bristol financial statements analysis is a perfect complement when working with Bristol Myers Valuation or Volatility modules.
  
Check out the analysis of Bristol Myers Correlation against competitors.

Latest Bristol Myers' Capital Stock Growth Pattern

Below is the plot of the Capital Stock of Bristol Myers Squibb over the last few years. It is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. Bristol Myers' Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bristol Myers' overall financial position and show how it may be relating to other accounts over time.
Capital Stock10 Years Trend
Slightly volatile
   Capital Stock   
       Timeline  

Bristol Capital Stock Regression Statistics

Arithmetic Mean252,494,000
Geometric Mean249,689,425
Coefficient Of Variation15.81
Mean Deviation35,805,750
Median221,000,000
Standard Deviation39,913,067
Sample Variance1593.1T
Range116.8M
R-Value0.80
Mean Square Error606.6T
R-Squared0.64
Significance0.0002
Slope6,730,824
Total Sum of Squares23895.8T

Bristol Capital Stock History

2025258.1 M
2024335.8 M
2019292 M
2012221 M
2011220 M
2010219 M

About Bristol Myers Financial Statements

Bristol Myers investors use historical fundamental indicators, such as Bristol Myers' Capital Stock, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bristol Myers. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Capital Stock335.8 M258.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bristol Stock Analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.